e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Management of sarcoidosis and lung manifestations of systemic diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comparative analysis of routine biochemistry data and neurohormonal markers in patients with different forms of pulmonary hypertension
Y. Andreeva, O. O. Matvienko, T. V. Martynyuk, N. M. Danilov, T. V. Kuznecova, V. P. Masenko, I. Y. Chazova (Moscow, Russian Federation)
Source:
Annual Congress 2010 - Management of sarcoidosis and lung manifestations of systemic diseases
Session:
Management of sarcoidosis and lung manifestations of systemic diseases
Session type:
Thematic Poster Session
Number:
606
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Andreeva, O. O. Matvienko, T. V. Martynyuk, N. M. Danilov, T. V. Kuznecova, V. P. Masenko, I. Y. Chazova (Moscow, Russian Federation). Comparative analysis of routine biochemistry data and neurohormonal markers in patients with different forms of pulmonary hypertension. Eur Respir J 2010; 36: Suppl. 54, 606
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Pulmonary sarcoidosis
Related content which might interest you:
Comparative analysis of the plasma metabolomics in rodent models of pulmonary hypertension and patients with IPAH shows different metabolic signatures
Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench
Year: 2019
Genetic findings in patients with different forms of pulmonary hypertension
Source: Virtual Congress 2020 – Genetics and genomics of pulmonary arterial hypertension
Year: 2020
Comparative evaluation of diagnosis methods in the patients with pulmonary sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 539s
Year: 2006
Proteomic profiling identifies an exercise signature in patients with pulmonary arterial hypertension
Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension
Year: 2020
Evaluation of the relationship between laboratory parameters and pulmonary function tests in COVID-19 patients
Source: Virtual Congress 2021 – COVID - 19 risk predictions
Year: 2021
Impact of the state of endothelium on clinical and functional parameters in COPD patients with arterial hypertension.
Source: International Congress 2017 – Novel mechanisms and treatments for COPD
Year: 2017
Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patients
Source: Eur Respir J 2014; 44: 951-962
Year: 2014
Analysis of miRNA profile in circulating microparticles of patients with pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
Combining physiology and imaging in the diagnosis of pulmonary hypertension
Source: International Congress 2019 – Breathing disorders, cardiovascular disease and pulmonary embolism guidelines
Year: 2019
Comparative assessment of hemodynamic parameters in patients with COPD and CHD treated with different groups of bronchodilators.
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018
A new molecular genetic diagnostic approach for pulmonary arterial hypertension
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016
Hemodynamic phenotypes in systemic sclerosis patients screened for pulmonary hypertension – impact of the new PH-definition
Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside
Year: 2019
Coagulation disorders in pulmonary hypertension. Correlations with haemodynamic data
Source: Eur Respir J 2003; 22: Suppl. 45, 437s
Year: 2003
The clinical role of routine non-invasive parameters in the diagnostic work-up of patients with risk for pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models
Year: 2012
Early diagnostic evaluation of pulmonary hypertension in severe COPD patients (preliminary results)
Source: Eur Respir J 2006; 28: Suppl. 50, 657s
Year: 2006
Genetic testing in pulmonary hypertension: how should our clinical practice reflect recent advances?
Source: Eur Respir J 2016; 47: 388-389
Year: 2016
Use of discriminant analysis to assess pulmonary functional worsening in patients with sarcoidosis by means of a panel of inflammatory markers
Source: Annual Congress 2011 - Biomarkers in sarcoidosis
Year: 2011
Non-invasive hemodynamic assessment in patients with pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Year: 2008
Comparison of sputum characteristics with clinical, laboratorial and functional variables in patients with stable COPD
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010
Comparative population-genetic analysis of pulmonary tuberculosis patients and lung cancer patients
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept